SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-129361
Filing Date
2024-05-02
Accepted
2024-05-02 16:08:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d819945ddefa14a.htm DEFA14A 17481
2 GRAPHIC g819945g0430225727078.jpg GRAPHIC 3902
3 GRAPHIC g819945g0430225727325.jpg GRAPHIC 3070
  Complete submission text file 0001193125-24-129361.txt   28471
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39979 | Film No.: 24908259
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)